Soluble CD27 as a predictive biomarker for intra‐tumoral CD70 / CD27 interaction in nasopharyngeal carcinoma
Cancer Science · 2024
DOI: 10.1111/cas.16079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Toshihiro Nagato und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
In CD70‐expressing tumors, the interaction of CD70 on tumor cells with its lymphocyte receptor, CD27, is thought to play a role in immunosuppression in the tumor microenvironment and elevated serum levels of soluble CD27 (sCD27). Previous studies showed that CD70 is expressed in nasopharyngeal carcinoma (NPC), an Epstein–Barr virus (EBV)‐related malignancy. However, the association between intratumoral CD70/CD27 expression and serum levels of sCD27 in NPC remains unclear. In the present study, we show that CD70 is primarily expressed by tumor cells in NPC and that CD27‐positive lymphocytes infiltrate around tumor cells. NPC patients with CD27‐positive lymphocytes had significantly better prognosis than patients lacking these cells. In addition, high CD70 expression by tumor cells tended to be correlated with shorter survival in NPC patients with CD27‐positive lymphocytes. Serum sCD27 levels were significantly increased in patients with NPC and provided good diagnostic accuracy for discriminating patients from healthy individuals. The concentration of serum sCD27 in patients with CD70‐positive NPC with CD27‐positive lymphocytes was significantly higher than in patients with tumors negative for CD70 and/or CD27, indicating that the intratumoral CD70/CD27 interaction boosts the release of sCD27. Furthermore, positive expression of CD70 by NPC cells was significantly correlated with EBV infection. Our results suggest that CD70/CD27‐targeted immunotherapies may be promising treatment options and that sCD27 may become an essential tool for evaluating the applicability of these therapies by predicting the intratumoral CD70/CD27 interaction in NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
- Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
- Department of Innovative Head and Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan.
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, Japan.
ORCID-Profile: Toshihiro Nagato, Hiroki Komatsuda, Takayuki Ohkuri, Takumi Kumai
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nagato, T., Komatsuda, H., Hayashi, R., Takahara, M., Ujiie, N., Kosaka, A., Ohkuri, T., Oikawa, K., Sato, R., Wakisaka, R., Kono, M., Yamaki, H., Ohara, K., Kumai, T., Kishibe, K., Katada, A., Hayashi, T., & Kobayashi, H. (2024). Soluble CD27 as a predictive biomarker for intra‐tumoral CD70 / CD27 interaction in nasopharyngeal carcinoma. Cancer Science. https://doi.org/10.1111/cas.16079
Vancouver
Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, et al. Soluble CD27 as a predictive biomarker for intra‐tumoral CD70 / CD27 interaction in nasopharyngeal carcinoma. Cancer Science. 2024. doi:10.1111/cas.16079
BibTeX
@article{Nagato2024,
author = {Nagato, Toshihiro and Komatsuda, Hiroki and Hayashi, Ryusuke and Takahara, Miki and Ujiie, Nanami and Kosaka, Akemi and Ohkuri, Takayuki and Oikawa, Kensuke and Sato, Ryosuke and Wakisaka, Risa and Kono, Michihisa and Yamaki, Hidekiyo and Ohara, Kenzo and Kumai, Takumi and Kishibe, Kan and Katada, Akihiro and Hayashi, Tatsuya and Kobayashi, Hiroya},
title = {Soluble CD27 as a predictive biomarker for intra‐tumoral CD70 / CD27 interaction in nasopharyngeal carcinoma},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16079}
}
EUVIMED